menu
    • menu

    Company profile for Alivio Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Alivio Therapeutics is developing the only inflammation-targeting technology that exists which allows for selective modulation of the immune system at the site of inflammation while avoiding systemic immunosuppression, which is a long sought-after goal in the treatment of auto-immune disease. The platform has been validated in ten different preclinical models of inflammatory disease with publications in top tier journals inclu...
    Alivio Therapeutics is developing the only inflammation-targeting technology that exists which allows for selective modulation of the immune system at the site of inflammation while avoiding systemic immunosuppression, which is a long sought-after goal in the treatment of auto-immune disease. The platform has been validated in ten different preclinical models of inflammatory disease with publications in top tier journals including Science Translational Medicine and Nature Communications. The company is developing an internal pipeline of drugs for difficult-to-treat gastrointestinal diseases that leverage the unique nature of the platform.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Alivio TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    501 Boylston Street | Suite 6102 | Boston, MA 02116
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.aliviotherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/hashtag/aliviotherapeutics

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PureTech buys out Alivio, boosting inflammatory disease pipeline
    PureTech buys out Alivio, boosting inflammatory disease pipeline

    17 Jun 2021

    // A. Al Idrus FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/puretech-buys-out-alivio-adding-inflammatory-disease-programs-to-its-pipeline

    A. Al Idrus FIERCEBIOTECH
    17 Jun 2021
    Share Share
    PureTech Health buys remaining 22 per cent of shares in Alivio Therapeutics
    PureTech Health buys remaining 22 per cent of shares in Alivio Therapeutics

    17 Jun 2021

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=139367&sid=2

    PHARMABIZ
    17 Jun 2021
    Share Share
    PureTech Acquires Remaining Interest in Founded Entity Alivio Therapeutics
    PureTech Acquires Remaining Interest in Founded Entity Alivio Therapeutics

    16 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210616005153/en/PureTech-Acquires-Remaining-Interest-in-Founded-Entity-Alivio-Therapeutics#:~:text=BOSTON%2D%2D(BUSINESS%20WIRE)%2D%2D,the%20remaining%2022%20percent%20of

    BUSINESSWIRE
    16 Jun 2021
    Share Share
    PureTech Acquires Remaining Interest in Founded Entity Alivio Therapeutics
    PureTech Acquires Remaining Interest in Founded Entity Alivio Therapeutics

    16 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210616005153/en

    BUSINESSWIRE
    16 Jun 2021
    Share Share
    Alivio Therapeutics receives $3.3m from US Department of Defense to support devp
    Alivio Therapeutics receives $3.3m from US Department of Defense to support devp

    05 Oct 2020

    // PHARMAFILE

    http://www.pharmafile.com/news/560659/alivio-therapeutics-receives-33m-us-department-defense-support-development-ibd-drug-cand

    PHARMAFILE
    05 Oct 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search